The enhancement of αSMA+ cells at the tumor site of the DEN/CCl4-treated Cxcl10−/− mice suggests that these cells might be gaining a cancer-associated fibroblast-like (CAFs) function. This evidence concerns the gene CXCL10 and cancer.